MetaspaceCommander, a groundbreaking NFT project, is set to make waves in the gaming industry. The project is community-driven, offering gamers the chance to own a unique piece of history while shaping the direction of the game. In the first phase of the project, MetaspaceCommander will be minting an exclusive collection of 4444 animated NFTs. Each […]
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) stock gained on Wednesday despite another bearish day in the broader markets, moving higher by about 3% and, at press time, adding another 5% to that increase. The bullish sentiment makes sense even in the face of market turmoils. IKT scored massively positive news from the FDA when it announced […]
Acurx Pharmaceuticals’ (NASDAQ: ACXP) earnings release is scheduled for Thursday, March 16, 2023. And like most biotechs, investors will be more focused on what the company says than what it posts. That’s typical. Clinical-stage drug development companies rarely post meaningful revenues. But, they provide guidance and clinical program updates, two areas where investors can appraise […]
SOBR Safe, Inc. (NASDAQ: SOBR) has historically proven it can decouple from weak broader markets. Now, they’re showing off another strength: despite its smallcap size, they can raise capital on shareholder-friendly terms. Not many other companies with roughly $30 million market caps can make the same claim. Quite to the contrary, in fact, as most […]
Delveinsight Business Research LLP As per DelveInsight, the Adenoid Cystic Carcinoma Market dynamics are anticipated to change in the coming years owing to the expected launch of upcoming therapies, rising awareness of Adenoid Cystic Carcinoma, and improvement in the research and development activities undertaken by major biotech companies. The emerging pipeline for the treatment of […]
Delveinsight Business Research LLP As per DelveInsight’s assessment, about 30+ key pharma and biotech companies are working on 34+ pipeline drugs in the Diabetic Foot Ulcers therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]
Delveinsight Business Research LLP As per DelveInsight’s assessment, about 85+ key pharma and biotech companies are working on 85+ pipeline drugs in the T-Cell Lymphoma therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are […]
Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Graft-Versus-Host Disease (GVHD) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]
Steakholder Foods (NASDAQ: STKH) is leading the charge in the cultivated meat industry with their unique printing technology and cellular agriculture biological knowledge. The company’s latest announcement has set the stage for an exciting new venture. Steakholder Foods’ subsidiary, Peace of Meat (PoM), is set to launch a cultivated avian product, with Singapore as their primary […]
ADO Beast 20F is a 20-inch mountain fat e-bike that is faster, stronger, and easier than ever. ADO EBIKE is excited to announce the launch of its latest product, the ADO Beast 20F fat tire ebike, on Geekbuying. This product launch is a testament to ADO’s commitment to providing reliable, safe, and environmentally friendly transportation […]
